| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.009 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |